Inge van Loo

607 total citations
7 papers, 462 citations indexed

About

Inge van Loo is a scholar working on Infectious Diseases, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Inge van Loo has authored 7 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Clinical Biochemistry and 2 papers in Molecular Biology. Recurrent topics in Inge van Loo's work include Bacterial Identification and Susceptibility Testing (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Bacterial biofilms and quorum sensing (2 papers). Inge van Loo is often cited by papers focused on Bacterial Identification and Susceptibility Testing (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Bacterial biofilms and quorum sensing (2 papers). Inge van Loo collaborates with scholars based in Netherlands, France and Poland. Inge van Loo's co-authors include Xander W. Huijsdens, D. Beaujean, Albert J. de Neeling, Andreas Voß, N. van de Sande-Bruinsma, Jan Kluytmans, Edine Tiemersma, Ewa Augustynowicz, J Slusarczyk and Jan Kluytmans and has published in prestigious journals such as Journal of Clinical Microbiology, Emerging infectious diseases and Vaccine.

In The Last Decade

Inge van Loo

7 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inge van Loo Netherlands	3	338	209	185	93	84	7	462
Michael J. Male United States	6	400 1.2×	258 1.2×	154 0.8×	66 0.7×	65 0.8×	6	527
Koen M. Verstappen Netherlands	15	340 1.0×	200 1.0×	141 0.8×	52 0.6×	107 1.3×	20	524
Daniel Benito Spain	15	427 1.3×	322 1.5×	173 0.9×	54 0.6×	99 1.2×	17	585
Erwin Verkade Netherlands	16	527 1.6×	302 1.4×	236 1.3×	85 0.9×	67 0.8×	20	674
Sarah Byrne United Kingdom	6	458 1.4×	203 1.0×	252 1.4×	127 1.4×	44 0.5×	9	627
Ulrika Grönlund Andersson Sweden	5	357 1.1×	223 1.1×	198 1.1×	59 0.6×	102 1.2×	6	529
H. M. E. Frénay Netherlands	7	504 1.5×	302 1.4×	261 1.4×	75 0.8×	45 0.5×	11	620
R Bax Netherlands	7	382 1.1×	261 1.2×	234 1.3×	114 1.2×	68 0.8×	9	573
Sarah van Alen Germany	9	343 1.0×	235 1.1×	132 0.7×	39 0.4×	54 0.6×	9	451
Nan van Leeuwen Netherlands	6	357 1.1×	223 1.1×	216 1.2×	82 0.9×	42 0.5×	7	484

Countries citing papers authored by Inge van Loo

Since Specialization

Citations

This map shows the geographic impact of Inge van Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge van Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge van Loo more than expected).

Fields of papers citing papers by Inge van Loo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge van Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge van Loo. The network helps show where Inge van Loo may publish in the future.

Co-authorship network of co-authors of Inge van Loo

This figure shows the co-authorship network connecting the top 25 collaborators of Inge van Loo. A scholar is included among the top collaborators of Inge van Loo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge van Loo. Inge van Loo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jaarsveld, Cornelia H.M. van, Inge van Loo, Greet J. Boland, et al.. (2022). Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders. Vaccine. 40(23). 3210–3215. 1 indexed citations

2.

Loo, Inge van, et al.. (2016). Adenovirus Infection in Immunocompetent Children: Not Always as Innocent as Assumed. Research Publications (Maastricht University). 2(2). 1017. 1 indexed citations

3.

Huijsdens, Xander W., Inge van Loo, & Jan Kluytmans. (2009). School Closure to Reduce Infl uenza Transmission. 1 indexed citations

4.

Huijsdens, Xander W., Inge van Loo, & Jan Kluytmans. (2009). SCCmecTyping in Methicillin-ResistantStaphylococcus aureusStrains of Animal Origin. Emerging infectious diseases. 15(1). 135b–136. 1 indexed citations

5.

Loo, Inge van, Xander W. Huijsdens, Edine Tiemersma, et al.. (2007). Emergence of Methicillin-ResistantStaphylococcus aureusof Animal Origin in Humans. Emerging infectious diseases. 13(12). 1834–1839. 351 indexed citations

6.

Griethuysen, Arjanne van, Inge van Loo, Alex van Belkum, et al.. (2005). Loss of themecAGene during Storage of Methicillin-ResistantStaphylococcus aureusStrains. Journal of Clinical Microbiology. 43(3). 1361–1365. 45 indexed citations

7.

Augustynowicz, Ewa, et al.. (2001). Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine. 20(3-4). 299–303. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact